SCHEMBL1753679

SCHEMBL1753679

CC(=O)C(C(N)=O)c1ccc(C(=O)O)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.48
TP53 P04637 1/20 0.48
ANPEP P15144 1/20 0.47
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
SRD5A2 P31213 3/20 0.43
CA1 P00915 6/20 0.42
CA2 P00918 6/20 0.42
CA12 O43570 4/20 0.42
CA9 Q16790 4/20 0.42
CA14 Q9ULX7 3/20 0.41
CA3 P07451 2/20 0.41
CA6 P23280 2/20 0.41
CA5A P35218 2/20 0.41
CA7 P43166 2/20 0.41
CA5B Q9Y2D0 2/20 0.41
TYR P14679 1/20 0.41
DRD1 P21728 1/20 0.41
CA4 P22748 1/20 0.41
PARP15 Q460N3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1753887 0.90 TSHR (0.55) TSHRTP53ANPEPALDH1A1SMN1; SMN2
SCHEMBL7680641 0.86 TSHR (0.50) TSHRTP53ANPEPALDH1A1SMN1; SMN2
SCHEMBL9374736 0.81 SRC (0.56) SMN1; SMN2KMT2AHPGD
SCHEMBL5440302 0.79 KIF11 (0.47) ALDH1A1SMN1; SMN2CA1CA2CA12
SCHEMBL5374859 0.79 ANPEP (0.55) TSHRTP53ANPEPALDH1A1SMN1; SMN2
Terephthalic Acid SCHEMBL28925185 0.78 TSHR (0.71) TSHRTP53ALDH1A1SMN1; SMN2SRD5A2
SCHEMBL2906772 0.78 TSHR (0.50) TSHRTP53ANPEPALDH1A1SMN1; SMN2
SCHEMBL38660598 0.78 BRD4 (0.57) TSHRALDH1A1SMN1; SMN2KMT2ACYP2C19
SCHEMBL10936588 0.75 TSHR (0.52) TSHRTP53ANPEPALDH1A1SMN1; SMN2
SCHEMBL8138198 0.75 ANPEP (0.55) TSHRTP53ANPEPALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158825-B2 Modified malonate derivatives MERCK SHARP & DOHME CORP. (US) 2012-04-17 US disclosed
US-20100160327-A1 Modified Malonate Derivatives MERCK SHARP & DOHME LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160327-A1 Modified Malonate Derivatives ME2, ME3, ME1 TSHR 1838/4885TP53 1553/4885ANPEP 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.